Covid-19 pill competing with Pfizer’s looks for quick approval in Japan
2 years, 10 months ago

Covid-19 pill competing with Pfizer’s looks for quick approval in Japan

Live Mint  

TOKYO : Drugmaker Shionogi & Co. said it plans to seek approval this month to sell its Covid-19 treatment pill in Japan after the company found that in human trials the pill had strong virus-fighting ability compared with Pfizer Inc.’s Paxlovid. Pfizer said its final-stage trial, which included more than 2,000 patients, showed Paxlovid cut the risk of hospitalization or death by 89% if patients took the pill within three days of diagnosis. Still, Shionogi said it believed its trials to date, covering about 400 mostly Japanese patients, would offer sufficient evidence to seek approval in Japan, where the Pfizer drug is expected to be approved shortly, but is likely to be in limited supply. Shionogi said it would file its application to Tokyo drug regulators in the next week or two and, if approved, Japanese patients could be getting the drug as soon as early March.

Japan Trial Patients Japanese Covid Drug Virus Pfizer Pill Paxlovid Shionogi  pill  shionogi  pfizers  quick  looks  competing  japan  paxlovid  placebo  trial  approval  covid19  pfizer  patients  virus  pills  drug

History of this topic

Paxlovid can soften chance of severe COVID. Why's it underused?
10 months, 2 weeks ago

Paxlovid can soften chance of severe COVID. Why's it underused?

Associated Press  

Tens of thousands of Americans are hospitalized with COVID-19 every week. “When you read in your local newspaper that in this hospital, they’ve got this many COVID patients, most of those are preventable hospitalizations,” said Dr. Amesh Adalja, a senior scholar at Johns Hopkins University who sees Paxlovid as a useful tool to treat COVID-19. “If people are on four …

Paxlovid can lessen the chance of a severe COVID-19 illness. Why is it underused?
10 months, 2 weeks ago

Paxlovid can lessen the chance of a severe COVID-19 illness. Why is it underused?

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. “When you read in your local newspaper that in …

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use
1 year, 6 months ago

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

Associated Press  

WASHINGTON — Pfizer received full approval on Thursday for its COVID-19 pill Paxlovid that’s been the go-to treatment against the coronavirus. The FDA granted full approval for adults with COVID-19 who face high risks of severe disease, which can lead to hospitalization or death. Paxlovid is the fourth drug for COVID-19 to receive full FDA approval and the first one …

Pfizer’s New Oral Anti-Viral Drug Lowers Risk of Post-Covid Condition, Study Shows
1 year, 8 months ago

Pfizer’s New Oral Anti-Viral Drug Lowers Risk of Post-Covid Condition, Study Shows

News 18  

Pfizer’s oral anti-viral drug, Paxlovid, shortly after Covid-19 infection is likely to reduce the risk of developing long Covid, a new study found. The study titled ‘Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition’ found that Nirmatrelvir – sold under the brand name Paxlovid, was associated with 26% less risk of post Covid-19 condition, 47% less risk …

COVID-19 pill Paxlovid moves closer to full FDA approval
1 year, 9 months ago

COVID-19 pill Paxlovid moves closer to full FDA approval

Firstpost  

Washington: Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The FDA said using Paxlovid in high-risk patients could prevent 1,500 COVID-19 deaths and 13,000 hospitalizations per week. The agency asked its panel of independent medical experts to address several lingering …

COVID-19 pill Paxlovid moves closer to full FDA approval
1 year, 9 months ago

COVID-19 pill Paxlovid moves closer to full FDA approval

Associated Press  

WASHINGTON — Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The FDA said using Paxlovid in high-risk patients could prevent 1,500 COVID-19 deaths and 13,000 hospitalizations per week. The agency asked its panel of independent medical experts to address several …

COVID-19 pill Paxlovid moves closer to full FDA approval
1 year, 9 months ago

COVID-19 pill Paxlovid moves closer to full FDA approval

LA Times  

Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisors Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The FDA said using Paxlovid in high-risk patients could prevent 1,500 COVID-19 deaths and 13,000 hospitalizations per week. Pfizer originally studied Paxlovid in the highest-risk COVID-19 patients: unvaccinated adults with other health …

Amid COVID surge, China approves America’s Paxlovid, an anti-viral drug: Why this is an unlikely move
1 year, 11 months ago

Amid COVID surge, China approves America’s Paxlovid, an anti-viral drug: Why this is an unlikely move

Firstpost  

China has been reluctant to take medicines and vaccines from the West. The oral antiviral has proved to cut the risk of hospitalisation and death The recent surge in COVID-19 cases has caused China’s healthcare infrastructure to crumble. Beijing will begin distributing American pharma giant Pfizer’s drug, Paxlovid, to community health centres in the city, according to a report by …

Study: Pfizer COVID pill showed no benefit in younger adults
2 years, 4 months ago

Study: Pfizer COVID pill showed no benefit in younger adults

Associated Press  

WASHINGTON — Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, according to a large study published Wednesday. The results from a 109,000-patient Israeli study are likely to renew questions about the U.S. government’s use of Paxlovid, which has become the go-to treatment for …

Pfizer COVID pill showed no benefit in adults under 65, study finds
2 years, 4 months ago

Pfizer COVID pill showed no benefit in adults under 65, study finds

LA Times  

Paxlovid may provide little benefit for adults younger than 65 with COVID-19 while still reducing the risk of hospitalization and death for higher-risk seniors, according to a new study from Israel. Pfizer’s COVID-19 pill appears to provide little or no benefit for adults under 65 while still reducing the risk of hospitalization and death for high-risk seniors, according to a …

Pfizer CEO tests positive for COVID-19, has mild symptoms
2 years, 4 months ago

Pfizer CEO tests positive for COVID-19, has mild symptoms

LA Times  

Albert Bourla, chief executive officer of Pfizer, speaks at the World Economic Forum in Davos, Switzerland, in May. Bourla said Monday that he has a very mild case of COVID-19 and has started taking Pfizer’s Paxlovid pill. The top executive at Pfizer, a leading producer of COVID-19 vaccines and medicines, has tested positive for the virus and says he is …

Oral pill for COVID-19 approved by regulator
2 years, 4 months ago

Oral pill for COVID-19 approved by regulator

China Daily  

China Daily| Updated :2022-07-29 China's top drug regulator said on Monday that it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19 disease, adding to the growing medical arsenal against the novel coronavirus. Azvudine, developed by the Genuine Biotech Co based in Henan province, was first conditionally approved to treat HIV-1 infected adult patients …

US allows pharmacists to prescribe Pfizer’s COVID-19 pill
2 years, 5 months ago

US allows pharmacists to prescribe Pfizer’s COVID-19 pill

Associated Press  

WASHINGTON — Pharmacists can prescribe the leading COVID-19 pill directly to patients under a new U.S. policy announced Wednesday that’s intended to expand use of Pfizer’s drug Paxlovid. The Food and Drug Administration said pharmacists can begin screening patients to see if they are eligible for Paxlovid and then prescribe the medication, which has been shown to curb the worst …

Pfizer says its COVID pill doesn’t work for healthier patients
2 years, 6 months ago

Pfizer says its COVID pill doesn’t work for healthier patients

LA Times  

Pfizer says it will focus its efforts on studying its COVID drug, Paxlovid, in vulnerable populations, including people who are immunocompromised or already in the hospital. Pfizer Inc. plans to stop enrollment in a study of its COVID-19 drug in patients who aren’t at high risk of severe disease after the pill didn’t help alleviate their symptoms, a major setback …

Rare cases of Covid relapse raise questions about Pfizer pill's performance
2 years, 7 months ago

Rare cases of Covid relapse raise questions about Pfizer pill's performance

India Today  

As more doctors prescribe Pfizer’s powerful Covid-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. Read: Covid-19 worsens asthma in children, finds study “The ability to clear the virus after it’s suppressed may be different from omicron to delta, especially for vaccinated people,” said Charness, who …

Rare cases of Covid relapse pose questions for Pfizer's Paxlovid pill
2 years, 7 months ago

Rare cases of Covid relapse pose questions for Pfizer's Paxlovid pill

India Today  

As more doctors prescribe Pfizer’s powerful Covid-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. READ | Why Pfizer’s new drug Paxlovid raises hopes against Covid Dr. Michael Charness reported last month on a 71-year-old vaccinated patient who saw his symptoms subside but then return, along …

Rare Cases Of COVID Returning Pose Questions For Pfizer Pill
2 years, 7 months ago

Rare Cases Of COVID Returning Pose Questions For Pfizer Pill

Huff Post  

FILE - In this photo provided by Pfizer, a lab technician visually inspects COVID-19 Paxlovid tablet samples in Freiburg, Germany in December 2021. As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. via Associated Press WASHINGTON — As more doctors …

Rare cases of COVID returning pose questions for Pfizer pill
2 years, 7 months ago

Rare cases of COVID returning pose questions for Pfizer pill

Associated Press  

WASHINGTON — As more doctors prescribe Pfizer’s powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. “The ability to clear the virus after it’s suppressed may be different from omicron to delta, especially for vaccinated people,” said Charness, who works for Boston’s VA health system. …

Why Pfizer's new drug Paxlovid raises hopes against Covid
2 years, 7 months ago

Why Pfizer's new drug Paxlovid raises hopes against Covid

India Today  

As Covid cases in India continue to rise, a new drug from pharma major Pfizer has helped ease some of the fears. The drug has already received emergency use authorisation in the US and the UK, and has been “strongly recommended” by WHO for non-severe Covid patients who are at the highest risk of hospitalisation. However, the medication was never …

Kamala Harris' COVID-19 being treated by Paxlovid: All you need to know about Pfizer's oral drug
2 years, 7 months ago

Kamala Harris' COVID-19 being treated by Paxlovid: All you need to know about Pfizer's oral drug

Firstpost  

Paxlovid, the oral drug, reduces the risk of COVID-19-associated hospitalisation or death by 89 per cent in those who receive treatment within three days of symptom onset The fight against coronavirus received yet another boost last Friday when the World Health Organization “strongly recommended” Pfizer’s COVID-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still …

Administration expands availability of COVID antiviral pill
2 years, 7 months ago

Administration expands availability of COVID antiviral pill

Associated Press  

WASHINGTON — President Joe Biden’s administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid, seeking to reassure doctors that there is ample supply for people at high risk of severe illness or death from the virus. “Paxlovid will be widely available everywhere in America,” said Dr. Ashish Jha, the White House COVID-19 response coordinator. The …

Japanese anti-Covid pill shows 'rapid clearance of virus', says developer
2 years, 8 months ago

Japanese anti-Covid pill shows 'rapid clearance of virus', says developer

India Today  

An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes Covid-19, according to new data, the Japanese drugmaker said on Sunday. The pill, S-217622, "demonstrated rapid clearance of the infectious SARS-CoV-2 virus", Shionogi said in a statement, citing Phase-2b results from the Phase II/III clinical trial of the drug. The findings released on …

Biden admin to promote availability of COVID antiviral pill
2 years, 8 months ago

Biden admin to promote availability of COVID antiviral pill

Associated Press  

WASHINGTON — President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed. A senior administration official said usage of the antiviral regimen has “more than doubled” over the last few weeks, but the administration …

WHO recommends Pfizer's pill Paxlovid for mild Covid cases
2 years, 8 months ago

WHO recommends Pfizer's pill Paxlovid for mild Covid cases

India Today  

The World Health Organisation has strongly recommended nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate Covid-19 patients at highest risk of hospital admission. Pfizer’s oral antiviral drug is strongly recommended for patients with non-severe Covid-19 who are at highest risk of developing severe disease and hospitalisation, such as unvaccinated, older, or immunosuppressed patients. The global health …

What is Paxlovid and Who Can Take Pfizer’s Covid-19 Wonder Drug ‘Strongly Recommended’ by WHO?
2 years, 8 months ago

What is Paxlovid and Who Can Take Pfizer’s Covid-19 Wonder Drug ‘Strongly Recommended’ by WHO?

News 18  

Paxlovid, Pfizer’s Covid-19 antiviral pill, has been “strongly recommended” by the World Health Organization for patients with milder forms of the disease who are still at high risk of hospitalisation. WHO experts have said that Pfizer’s oral treatment prevents hospitalisation more than the “available alternatives, has fewer concerns with respect to harms than Molnupiravir, and is easier to administer than …

WHO 'strongly recommends' Pfizer's Covid pill | 5 things to know about Paxlovid
2 years, 8 months ago

WHO 'strongly recommends' Pfizer's Covid pill | 5 things to know about Paxlovid

Hindustan Times  

The World Health Organization on Friday “strongly recommended” the use of Pfizer's antiviral pill Paxlovid in patients with mild and moderate forms of coronavirus disease at the highest risk of hospitalisation. 5 things you need to know about Pfizer's antiviral pill: Paxlovid is a combination of nirmatrelvir and ritonavir tablets and is administered orally. While the brand name drug, sold …

COVID-19 pills could be a game-changer, but doctors trying to use them face hurdles
2 years, 9 months ago

COVID-19 pills could be a game-changer, but doctors trying to use them face hurdles

LA Times  

Jeff Carlson, a Type 1 diabetic with heart stents, came down with COVID-19 in January, but recovered quickly after being treated with Merck’s molnupiravir. With vaccines and treatments available, “we can make this much more manageable in the future, if people are willing to take care of themselves,” said Dr. Bryan Jarabek, who helps lead COVID-19 treatment and vaccination efforts …

COVID-19 pill rollout stymied by shortages as omicron rages
2 years, 11 months ago

COVID-19 pill rollout stymied by shortages as omicron rages

Associated Press  

WASHINGTON — Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. “This should be a really joyous time because we now have highly effective antiviral pills,” said Erin McCreary, a pharmacist and administrator …

COVID-19 pill rollout stymied by shortages as Omicron rages
2 years, 11 months ago

COVID-19 pill rollout stymied by shortages as Omicron rages

LA Times  

A worker handles Paxlovid pills, which are made by Pfizer to treat COVID-19. “This should be a really joyous time because we now have highly effective antiviral pills,” said Erin McCreary, a pharmacist and administrator at the University of Pittsburgh Medical Center. “Instead, this feels like the hardest and most chaotic stretch of the pandemic.” The pills — and other …

Pfizer’s Covid-19 antiviral pill was hailed as a game-changer, but supplies are scarce
2 years, 11 months ago

Pfizer’s Covid-19 antiviral pill was hailed as a game-changer, but supplies are scarce

CNN  

CNN — The Omicron variant of the coronavirus is causing Covid-19 cases to spike, with an average of more than 747,000 new cases a day, according to the latest numbers from Johns Hopkins University. “We’re using these medications judiciously and really giving them to the people that would most benefit from these therapeutics,” Dhanireddy said. I think the whole idea …

New easy-to-use Covid-19 pills come with a catch. Here's how
2 years, 11 months ago

New easy-to-use Covid-19 pills come with a catch. Here's how

India TV News  

Newly infected COVID-19 patients have two new treatment options that can be taken at home. The pills are intended for those with mild or moderate COVID-19 who are more likely to become seriously ill. That includes older people and those with other health conditions like heart disease, cancer or diabetes that make them more vulnerable. Antiviral pills aren't authorized for …

Paxlovid and Molnupiravir | A new front in the battle against the pandemic
2 years, 11 months ago

Paxlovid and Molnupiravir | A new front in the battle against the pandemic

The Hindu  

The U.S. Food and Drugs Administration has given an Emergency Use Authorisation to two drugs: Paxlovid, a treatment regimen developed by Pfizer Inc for treating mild-to-moderate Covid-19 in adults and children 12 years and older, who are likely to be at greater risk for severe infection, and Molnupiravir, developed by Merck and Ridgeback Biotherapeutics to treat mild-to-moderate COVID-19 in adults …

US adds Merck pill as 2nd easy-to-use drug against COVID-19
3 years ago

US adds Merck pill as 2nd easy-to-use drug against COVID-19

Associated Press  

WASHINGTON — U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The FDA authorized Merck’s drug for adults with a positive COVID-19 test, early symptoms and who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. Additionally, …

US President Joe Biden calls COVID pandemic pill 'significant step'
3 years ago

US President Joe Biden calls COVID pandemic pill 'significant step'

India TV News  

Highlights US health regulators on Wednesday authorised 1st pill against COVID President Joe Biden said it marks a "significant step forward" on path out of COVID pandemic Pill is Pfizer drug that Americans will be able to take at home to head off worst effects of COVID US health regulators on Wednesday authorised the first pill against COVID-19, and President …

Pfizer's oral Covid-19 pill gets US authorisation for at-home use
3 years ago

Pfizer's oral Covid-19 pill gets US authorisation for at-home use

India TV News  

U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that …

US adds Merck pill as 2nd easy-to-use drug against Covid-19
3 years ago

US adds Merck pill as 2nd easy-to-use drug against Covid-19

India Today  

US health regulators on Thursday authorised the second pill against Covid-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and Drug Administration authorized Merck's drug for adults with early symptoms of Covid-19 who face the highest risks of hospitalisation, including older people and those with conditions like obesity and heart disease. Additionally, Pfizer's drug …

Merck’s at-home antiviral COVID-19 pill approved by US regulator
3 years ago

Merck’s at-home antiviral COVID-19 pill approved by US regulator

Al Jazeera  

United States health regulators have authorised a second antiviral pill against COVID-19, providing another easy-to-use medication to battle the rising tide of Omicron infections. Additionally, Pfizer’s drug was roughly three times more effective in testing than Merck’s, reducing hospitalisation and death by nearly 90 percent among high-risk patients. Merck’s drug is not authorised for use in patients younger than 18 …

Pfizer pill becomes 1st US-authorized home COVID treatment
3 years ago

Pfizer pill becomes 1st US-authorized home COVID treatment

Associated Press  

WASHINGTON — U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron …

Pfizer Pill Becomes First US-authorized Home Covid-19 Treatment
3 years ago

Pfizer Pill Becomes First US-authorized Home Covid-19 Treatment

News 18  

U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that …

Pfizer pill becomes 1st U.S.-authorized home COVID treatment
3 years ago

Pfizer pill becomes 1st U.S.-authorized home COVID treatment

LA Times  

Americans will be able to take a pill by Pfizer at home to head off the worst effects of the coronavirus. U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the coronavirus. But Pfizer’s drug is all but certain …

European Medicines Agency recommends emergency use of Pfizer Covid-19 pill
3 years ago

European Medicines Agency recommends emergency use of Pfizer Covid-19 pill

India TV News  

Highlights Paxlovid should be administered as soon as possible after diagnosis of Covid-19. The European Medicines Agency has issued advice on the emergency use of Pfizer's Covid-19 pill called Paxlovid. EMA said it issued this advice to support national authorities who may decide on possible early use of the medicine prior to marketing authorization, for example in emergency use settings, …

Pfizer confirms COVID pill’s results, potency versus omicron
3 years ago

Pfizer confirms COVID pill’s results, potency versus omicron

Associated Press  

WASHINGTON — Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms. The Food and …

Pfizer confirms COVID pill’s results, potency versus Omicron
3 years ago

Pfizer confirms COVID pill’s results, potency versus Omicron

The Hindu  

Pfizer said on Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms. The Food and Drug Administration is …

Pfizer says its COVID pill near 90% effective in clinical trials
3 years ago

Pfizer says its COVID pill near 90% effective in clinical trials

Al Jazeera  

The company says it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million in 2022. Pfizer Inc has said the final analysis of its antiviral COVID-19 pill showed close to 90 percent efficacy in preventing hospitalisations and deaths in high-risk patients with recent lab data suggesting the drug retains its effectiveness …

Pfizer confirms Covid pill's potency against Omicron variant
3 years ago

Pfizer confirms Covid pill's potency against Omicron variant

India Today  

Pfizer said Tuesday that its experimental Covid-19 pill appears effective against the Omicron variant. The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89 per cent among high-risk adults when taken shortly after initial Covid-19 symptoms. The Food and Drug Administration …

Pfizer says its COVID-19 treatment pill works against the Omicron variant
3 years ago

Pfizer says its COVID-19 treatment pill works against the Omicron variant

LA Times  

Pfizer says its COVID-19 treatment pill appears to be effective against the Omicron variant. Pfizer said Tuesday that its experimental COVID-19 pill appears to be effective against the Omicron variant of the coronavirus. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by …

Pfizer Covid-19 antiviral pill: Biden says he’s ‘encouraged by the promising data’
3 years ago

Pfizer Covid-19 antiviral pill: Biden says he’s ‘encouraged by the promising data’

CNN  

Washington CNN — President Joe Biden on Tuesday praised Pfizer’s report that its experimental treatment for Covid-19 cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms. “I am encouraged by the promising data released by Pfizer today, showing that its antiviral pill is effective at reducing the …

Merck’s covid-19 pill backed by FDA advisers
3 years ago

Merck’s covid-19 pill backed by FDA advisers

Live Mint  

An outside panel of scientific advisers to the Food and Drug Administration narrowly recommended the agency authorize the experimental Covid-19 oral antiviral from Merck & Co. and partner Ridgeback Biotherapeutics LP. Several panel members who voted in favor of authorization said use of molnupiravir should be limited to unvaccinated people at high risk of Covid-19 complications, and that while more …

US panel backs Merck's first-of-a-kind Covid-19 pill
3 years ago

US panel backs Merck's first-of-a-kind Covid-19 pill

Hindustan Times  

A panel of US health advisers on Tuesday narrowly backed a closely watched Covid-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus. A Food and Drug Administration panel voted 13-10 that the drug’s benefits outweigh its risks, including potential birth defects if used during …

Discover Related